BridgeMD
New treatment option for Anxiety
Official title Mobile Cognitive Behavioral Therapy for Stroke
ClinicalTrials.gov ID: NCT06689878
What this study is testing
- What it's testing
- This study aims to assess the feasibility and acceptability of "MAYA", a mobile cognitive behavioral therapy app for anxiety and mood disorders, in adults who have had a stroke.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 79
You may be able to join if
- Age 40-79
- Presence of clinically-significant anxiety and/or depression (as determined by an eligibility evaluation)
- Stroke that occurred 1 month or more prior to study initiation
- Capacity to provide consent
- No greater than mild cognitive difficulties based on an eligibility evaluation conducted as part of the study
You likely can't join if
- Aphasia of moderate or greater severity (as determined during an eligibility evaluation)
- Non-fluency in English
- History of a bipolar or psychotic disorder
- Current alcohol or substance use disorder
- Active suicidal ideation
- Current engagement in psychotherapy is not grounds for exclusion unless the individual's psychotherapy is primarily focused on CBT
See the full eligibility criteria
- Age 40-79
- Presence of clinically-significant anxiety and/or depression (as determined by an eligibility evaluation)
- Stroke that occurred 1 month or more prior to study initiation
- Capacity to provide consent
- No greater than mild cognitive difficulties based on an eligibility evaluation conducted as part of the study
- If taking medication for depression and/or anxiety, must be on a stable dose for a minimum of 8 weeks prior to study initiation
- Ability to use iPhone or iPad independently
- Home internet access
- Willingness to participate in the full study duration.
- Aphasia of moderate or greater severity (as determined during an eligibility evaluation)
- Non-fluency in English
- History of a bipolar or psychotic disorder
- Current alcohol or substance use disorder
- Active suicidal ideation
- Current engagement in psychotherapy is not grounds for exclusion unless the individual's psychotherapy is primarily focused on CBT
- Severe depression and/or anxiety based on the initial evaluation and clinical judgment of the study doctor, which warrants a higher level of care and/or immediate referral to psychiatric services
- Any other clinical or medical reason in the study doctor's initial screening evaluation that suggests the study is not appropriate for the participant
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 79 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.